Immune thrombocytopenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-70 years, male or female; 2. Diagnosed with primary immune thrombocytopenia, the diagnostic criteria meet the "Chinese Guidelines for the Diagnosis and Treatment of Primary Immune Thrombocytopenia in Adults (2020)", and the platelet count × 30109/L = <100×109/L; 3. Do not take any drugs that interfere with platelet count during the test. Voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe heart, kidney, lung or liver dysfunction; 2. Patients with a history of severe mental disorders or inability to comply with research and follow-up procedures 3. Patients with immune thrombocytopenia with platelet count < 30×109/L; 4. Women who are pregnant or lactating; 5. Those who are allergic to any component of the known test drug;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CBC — platelet count;Bleeding score; | — |
Secondary
| Measure | Time frame |
|---|---|
| ITP-PAQ questionnaire; | — |
Countries
CHINA
Contacts
First Hospital of Shanxi Medical University